7-羟基-4-苯基-2-萘甲酸甲酯 | 156152-25-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 中文名称: 7-羟基-4-苯基-2-萘甲酸甲酯
• 英文名称: methyl 7-hydroxy-4-phenyl-2-naphthoate
• 英文别名: 1-phenyl-3-carbomethoxy-6-naphthol；methyl 7-hydroxy-4-phenylnaphthalene-2-carboxylate
• CAS: 156152-25-9
• 化学式: C₁₈H₁₄O₃
• 分子量: 278.307
• InChiKey: YVUXLHOKNGBRDU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  21
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  7-羟基-4-苯基-2-萘甲酸甲酯 在 二异丁基氢化铝 作用下， 以 四氢呋喃 、 甲醇 、 四氯化碳 、 二氯甲烷 为溶剂， 生成 1-phenyl-3-chloromethyl-6-naphthol
  参考文献：
  名称：

  Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis

  摘要：

  具有公式I: ##STR1## 的化合物是白三烯生物合成抑制剂。这些化合物可用作抗哮喘、抗过敏、抗炎和细胞保护剂。它们还可用于治疗心绞痛、脑痉挛、肾小球肾炎、肝炎、内毒素血症、葡萄膜炎和移植排斥，并可预防动脉粥样硬化斑块的形成。

  公开号：

  US05308852A1
• 作为产物：
  描述：

  7-methoxy-4-phenyl-2-naphthoic acid 在 氯化亚砜 、 吡啶盐酸盐 作用下， 反应 28.0h， 生成 7-羟基-4-苯基-2-萘甲酸甲酯
  参考文献：
  名称：

  Dioxabicyclooctanyl Naphthalenenitriles as Nonredox 5-Lipoxygenase Inhibitors:  Structure−Activity Relationship Study Directed toward the Improvement of Metabolic Stability

  摘要：

  Naphthalenic lignan lactone 3a (L-702,539), a potent and selective 5-lipoxygenase (5-LO) inhibitor, is extensively metabolized at two different sites: the tetrahydropyran and the lactone rings. Early knowledge of the metabolic pathways triggered and directed a structure-activity relationship study aimed toward the improvement of metabolic stability in this series. The best modifications discovered, i.e., replacement of the lactone ring by a nitrile group, replacement of the tetrahydropyran ring by a 6,8-dioxabicydo[3.2.1]octanyl moiety, and replacement of the pendant phenyl ring by a 3-furyl ring, were incorporated in a single molecule to produce inhibitor 9ac (L-708,780). Compound 9ac inhibits the oxidation of arachidonic acid to 5-hydroperoxy-eicosatetraenoic acid by 5-LO (IC50 = 190 nM) and the formation of leukotriene B-4 in human polymorphonuclear leukocytes (IC50 = 3 nM) as well as in human whole blood (IC50 = 150 nM). The good inhibitory profile shown by naphthalenenitrile 9ac is accompanied by an improved resistance to oxidative metabolism. In addition, 9ac is orally active in the functional model of antigen-induced bronchoconstriction in allergic squirrel monkeys (95% inhibition at 0.1 mg/kg).

  DOI：

  10.1021/jm960301c

文献信息

• [EN] SUBSTITUTED 2-NAPHTHOIC ACIDS AS ANTAGONISTS OF GPR105 ACTIVITY<br/>[FR] ACIDES 2-NAPHTOÏQUE SUBSTITUÉS EN TANT QU'ANTAGONISTES DE L'ACTIVITÉ DE GPR105
  申请人：MERCK FROSST CANADA LTD

  公开号：WO2009070873A1

  公开（公告）日：2009-06-11

  Substituted 2-naphthoic acids of structural formula I are effective as antagonists of the biological activity of GPR105 protein. They are useful for the treatment, control or prevention of disorders responsive to antagonism of this receptor, such as diabetes, particularly, Type 2 diabetes, insulin resistance, hyperglycemia, lipid disorders, obesity, atherosclerosis, and conditions associated with the Metabolic Syndrome.

  结构式I中的2-萘甲酸替代物对GPR105蛋白的生物活性具有拮抗作用。它们可用于治疗、控制或预防对该受体拮抗有响应的疾病，如糖尿病，特别是2型糖尿病，胰岛素抵抗，高血糖，脂质紊乱，肥胖，动脉粥样硬化以及与代谢综合征相关的疾病。
• Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
  申请人：Merck Frosst Canada, Inc.

  公开号：US05308852A1

  公开（公告）日：1994-05-03

  Compounds having the formula I: ##STR1## are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis and allograft rejection and in preventing the formation of atherosclerotic plaques.

  具有公式I: ##STR1## 的化合物是白三烯生物合成抑制剂。这些化合物可用作抗哮喘、抗过敏、抗炎和细胞保护剂。它们还可用于治疗心绞痛、脑痉挛、肾小球肾炎、肝炎、内毒素血症、葡萄膜炎和移植排斥，并可预防动脉粥样硬化斑块的形成。
• [EN] HETEROARYLNAPHTHALENES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS<br/>[FR] HETEROARYLNAPHTALENES UTILISES COMME INHIBITEURS DE LA BIOSYNTHESE DE LEUCOTRIENE
  申请人：MERCK FROSST CANADA INC.

  公开号：WO1994000444A1

  公开（公告）日：1994-01-06

  (EN) Compounds having formula (I), are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis and allograft rejection and in preventing the formation of atherosclerotic plaques.(FR) Composés répondant à la formule (I), et servant d'inhibiteurs de la biosynthèse de leucotriène. Ces composés sont utiles en tant qu'agents antiasthmatiques, antiallergiques, anti-inflammatoires et cytoprotecteurs. Ils sont également utiles dans le traitement de l'angine, du spasme cérébral, de la glomérulonéphrite, de l'hépatite, de l'endotoxémie, de l'uvéite et du rejet d'allogreffe, ainsi que dans la prévention de la formation de plaques athéroscléreuses.

  化合物具有公式（I），是白三烯生物合成的抑制剂。这些化合物可用作抗哮喘，抗过敏，抗炎和细胞保护剂。它们还可用于治疗心绞痛，脑痉挛，肾小球肾炎，肝炎，内毒素血症，葡萄膜炎和同种异体移植排斥，并防止动脉粥样硬化斑块的形成。
• SUBSTITUTED 2-NAPHTHOIC ACIDS AS ANTAGONISTS OF GPR105 ACTIVITY
  申请人：Belley Michel

  公开号：US20100298347A1

  公开（公告）日：2010-11-25

  Substituted 2-naphthoic acids of structural formula are effective as antagonists of the biological activity of GPR105 protein. They are useful for the treatment, control or prevention of disorders responsive to antagonism of this receptor, such as diabetes, particularly, Type 2 diabetes, insulin resistance, hyperglycemia, lipid disorders, obesity, atherosclerosis, and conditions associated with the Metabolic Syndrome.

  具有以下结构式的2-萘甲酸替代物是GPR105蛋白生物活性的拮抗剂，对于治疗、控制或预防对此受体的拮抗作用有响应的疾病非常有效，包括糖尿病，特别是2型糖尿病，胰岛素抵抗，高血糖，脂质异常，肥胖症，动脉粥样硬化以及与代谢综合征相关的疾病。
• US5308852A
  申请人：——

  公开号：US5308852A

  公开（公告）日：1994-05-03